Julian Pardo

13 April 2026

Clinical trial in Zaragoza: a live cancer drug will be manufactured in a special room at the Servet Hospital for a single patient

A new CAR-T therapy for rare cancers, developed by researchers in Aragon, reprograms each person's immune cells to attack the tumor.
3 June, 2024

A new therapeutic approach would reduce mortality from COVID-19

An international study led by Julián Pardo, a researcher at the University of Zaragoza and the IIS Aragón, opens the way to more effective therapies, by reducing inflammation and preventing respiratory failure.
November 7, 2023

Two members of the IIS Aragón are part of the team studying a new line of research against cancer

Pedro Baptista and Julián Pardo are the members of IIS Aragón who will work on this new line of research to unravel the mechanisms that reduce the effectiveness of CAR-T cell therapy.